Feedback / Questions
INX-315 - Incyclix Bio, Pharmacosmos
https://www.globenewswire.com/news-release/2025/04/29/3070088/0/en/Incyclix-Bio-Granted-U-S-FDA-Fast-Track-Designation-for-INX-315-to-Treat-CCNE1-Amplified-Platinum-Resistant-Refractory-Ovarian-Cancer.html
Apr 29, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next